Mouwasat Medical Services Co. vs Dallah Healthcare Co.
A head-to-head of Mouwasat Medical Services Co. (4002) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4002 | 4004 |
|---|---|---|
| Market Cap | 12.18B SAR | 10.78B SAR |
| P/E (TTM) | 14.82 | 20.02 |
| Forward P/E | 13.87 | 20.80 |
| P/S | 4.02 | 2.67 |
| P/B | 3.06 | 2.64 |
| EV/EBITDA | 12.54 | 20.79 |
| Dividend Yield | 6.24% | 1.79% |
| Profit Margin | 25.09% | 11.15% |
| Gross Margin | 42.25% | 35.71% |
| Operating Margin | 26.98% | 15.40% |
| Revenue Growth (YoY) | +9.09% | +21.68% |
| FCF Yield | 5.10% | -0.21% |
| Debt / Equity | 28.00 | 94.09 |
| Current Ratio | 1.62 | 1.20 |
Which is better: Mouwasat Medical Services Co. or Dallah Healthcare Co.?
- ✓Larger by market cap: Mouwasat Medical Services Co.
- ✓Cheaper valuation (lower P/E): Mouwasat Medical Services Co.
- ✓Higher dividend yield: Mouwasat Medical Services Co.
- ✓More profitable (net margin): Mouwasat Medical Services Co.
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Mouwasat Medical Services Co.
Across 13 available metrics, Mouwasat Medical Services Co. leads 10–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Mouwasat Medical Services Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.